---

Efficacy of amniotic membrane graft in ocular surface disorders

---

Original Article

Author Details : Rani Sujatha M A, Varsha A*

Volume : 6, Issue : 3, Year : 2020

Article Page : 449-451

https://doi.org/10.18231/j.ijceo.2020.096

Suggest article by email

Get Permission

---

Abstract

Amniotic membrane transplantation is the newest approach to limbal stem cell transplantation for
the reconstruction of ocular surface disorders. Amniotic membrane grafting helps in promoting
epithelialisation, decreasing inflammation and suppressing fibrosis.
Purpose: To evaluate the use of amniotic membrane graft in patients coming to Dr B.R. Ambedkar Medical
college OPD and IPD with various ocular surface disorders.
Materials and Methods: The prospective interventional study was conducted over a period of 18 months
from June 2017 to November 2018 at DR. B. R. Ambedkar medical college and hospital, Bengaluru.
A total of 46 eyes of 46 patients were taken into the study. Consecutive patients with ocular surface
disorders including primary pterygia and chemical injury underwent amniotic membrane transplantation
and were followed for 6 months.
Results: In our study, 46 patients were enrolled including 26 males and 20 females with mean age of
43.3 +/- 12.97 years. Of these, there were 40 patients with Pterygium (87%), 6 patient’s had chemical burn
(13%). Out of 40 cases with primary pterygium, 35 cases (87.5%) showed no recurrences at the 6th month
of follow up, 5 cases (12.5%) showed superficial vascularisation and re-growth upto 2mm crossing the
limbal margin. The recurrence was early in two cases (5%) and late in three cases (7.5%). Out of 6 cases
with chemical injury, 4 patients (66.6%) had successful outcome.
Conclusion: Amniotic membrane transplantation is a safe and effective surgical technique for ocular
surface disorders.

Keywords: Amniotic membrane transplantation, Ocular surface disorders.

How to cite : Rani Sujatha M A, Varsha A, Efficacy of amniotic membrane graft in ocular surface disorders. Indian J Clin Exp Ophthalmol 2020;6(3):449-451

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.